Literature DB >> 29785650

A Probiotic for Ulcerative Colitis: The Culture Wars Continue.

Bincy P Abraham1, Eamonn M M Quigley2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29785650     DOI： 10.1007/s10620-018-5097-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  24 in total

Review 1.  Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.

Authors:  Abigail R Basson; Minh Lam; Fabio Cominelli
Journal:  Gastroenterol Clin North Am       Date:  2017-12       Impact factor: 3.806

2.  Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic.

Authors:  Colin Hill; Francisco Guarner; Gregor Reid; Glenn R Gibson; Daniel J Merenstein; Bruno Pot; Lorenzo Morelli; Roberto Berni Canani; Harry J Flint; Seppo Salminen; Philip C Calder; Mary Ellen Sanders
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-06-10       Impact factor: 46.802

Review 3.  Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management.

Authors:  J McIlroy; G Ianiro; I Mukhopadhya; R Hansen; G L Hold
Journal:  Aliment Pharmacol Ther       Date:  2017-10-16       Impact factor: 8.171

Review 4.  Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.

Authors:  Y Derwa; D J Gracie; P J Hamlin; A C Ford
Journal:  Aliment Pharmacol Ther       Date:  2017-06-27       Impact factor: 8.171

Review 5.  Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet?

Authors:  Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-30       Impact factor: 46.802

6.  Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study.

Authors:  Hideki Ishikawa; Satoshi Matsumoto; Yuji Ohashi; Akemi Imaoka; Hiromi Setoyama; Yoshinori Umesaki; Ryuichiro Tanaka; Toru Otani
Journal:  Digestion       Date:  2011-04-28       Impact factor: 3.216

7.  Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials.

Authors:  Jun Shen; Zhi-Xiang Zuo; Ai-Ping Mao
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

Review 8.  Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.

Authors:  Neeraj Narula; Zain Kassam; Yuhong Yuan; Jean-Frederic Colombel; Cyriel Ponsioen; Walter Reinisch; Paul Moayyedi
Journal:  Inflamm Bowel Dis       Date:  2017-10       Impact factor: 5.325

9.  Antimicrobial susceptibility of Bifidobacterium breve strains and genetic analysis of streptomycin resistance of probiotic B. breve strain Yakult.

Authors:  Mayumi Kiwaki; Takashi Sato
Journal:  Int J Food Microbiol       Date:  2009-07-01       Impact factor: 5.277

Review 10.  Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation.

Authors:  Zhao-Hua Shen; Chang-Xin Zhu; Yong-Sheng Quan; Zhen-Yu Yang; Shuai Wu; Wei-Wei Luo; Bei Tan; Xiao-Yan Wang
Journal:  World J Gastroenterol       Date:  2018-01-07       Impact factor: 5.742
View more
  1 in total

1.  Effects of soy milk consumption on gut microbiota, inflammatory markers, and disease severity in patients with ulcerative colitis: a study protocol for a randomized clinical trial.

Authors:  Omid Sadeghi; Alireza Milajerdi; Seyed Davar Siadat; Seyed Ali Keshavarz; Ali Reza Sima; Homayoon Vahedi; Peyman Adibi; Ahmad Esmaillzadeh
Journal:  Trials       Date:  2020-06-23       Impact factor: 2.279
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.